Regulations.gov document
Risk-Based Licensing of Biosimilars re Memorandum of Meeting - Listening Meeting with Dr…
Supporting & Related Material · FDA-2019-P-1236 · posted Jul 11, 2019
Key facts
| Document ID | FDA-2019-P-1236-0005 |
|---|---|
| Title | Risk-Based Licensing of Biosimilars re Memorandum of Meeting - Listening Meeting with Dr. Sarfaraz Niazi regarding biosimilars |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2019-P-1236 |
| Posted | Jul 11, 2019 |
| Effective date | Apr 11, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: